相关实验视频

Updated: Jan 7, 2026

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

"Breg-Treg"与"Th9-Th17"细胞轴在绝经后骨质疏松症中的免疫治疗潜力

Asha Bhardwaj¹, Leena Sapra^1,2, Rupesh K Srivastava¹

¹Translational Immunology, Osteoimmunology & Immunoporosis Lab (TIOIL), An ICMR Collaborating Centre for Excellence on Bone Health, Department of Biotechnology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

International reviews of immunology

|December 26, 2025

概括

新的研究强调了Breg和Th9免疫细胞在调节骨质稳定中的关键作用,为绝经后骨质疏松症 (PMO) 提供了潜在的新治疗点. 这一发现可能会导致治疗的副作用比目前的选择少.

科学领域:

免疫学免疫学免疫学
骨生物学骨生物学骨生物学
内分泌学在内分泌学.

背景情况:

绝经后骨质疏松症 (PMO) 是一种由雌激素缺乏引起的常见骨疾病,需要长期管理.
目前的PMO治疗面临着副作用和停止后潜在的反弹效应的挑战.
新出现的证据表明,PMO病变发生时免疫系统的调节失调.

研究的目的:

审查了解布雷格细胞和Th9细胞在骨质平衡中的作用的最新进展.
在PMO中探索Breg-Treg和Th9-Th17细胞轴之间的相互作用.
讨论针对PMO这些免疫细胞轴的新型治疗策略.

主要方法:

关于免疫细胞和骨代谢的最新研究的文献综述.
分析骨完整性中的Breg,Th9,Treg和Th17细胞的调节机制.
在PMO中对Breg-Treg与Th9-Th17细胞轴的当前知识的综合.

主要成果:

Treg和Th17细胞是已知的骨质细胞分化的调节者和骨质稳定.
布雷格细胞和Th9细胞在调节骨质恒温中发挥着重要作用.
这些细胞直接影响骨细胞的发育,调节Treg-Th17平衡.

结论:

在PMO病理生理学中,Breg-Treg和Th9-Th17细胞之间的相互作用可能比以前认为的更为关键.
了解这种更广泛的免疫网络为骨质稳定和骨质疏松症进展提供了新的视角.
针对Breg-Treg-Th9-Th17轴为新的PMO诊断和治疗提供了一个有希望的途径.

关键词:

抗IL-9疗法是一种治疗方法.布雷格斯 (Bregs) 是一个在Th17细胞中.在Th9细胞中.这是Tregs.我们的肠道微生物群.免疫性疏松症免疫性疏松症绝经后的骨质疏松症

更多相关视频

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...